148 related articles for article (PubMed ID: 12556972)
1. Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.
Szende B; Horváth A; Bökönyi G; Kéri G
Br J Cancer; 2003 Jan; 88(1):132-6. PubMed ID: 12556972
[TBL] [Abstract][Full Text] [Related]
2. TT-232: a somatostatin structural derivative as a potent antitumor drug candidate.
Szende B; Kéri G
Anticancer Drugs; 2003 Sep; 14(8):585-8. PubMed ID: 14501379
[TBL] [Abstract][Full Text] [Related]
3. A novel plasmin-inhibitor inhibits the growth of human tumor xenografts and decreases metastasis number.
Szende B; Okada Y; Tsuda Y; Horvath A; Bökönyi G; Okamoto S; Wanaka K; Kéri G
In Vivo; 2002; 16(5):281-6. PubMed ID: 12494864
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.
Tejeda M; Gaál D; Hullán L; Schwab R; Szokoloczi O; Kéri G
Anticancer Res; 2007; 27(6B):4015-9. PubMed ID: 18225564
[TBL] [Abstract][Full Text] [Related]
5. Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.
Tejeda M; Gaal D; Hullán L; Csuka O; Schwab R; Szokoloczi O; Kéri GY
Anticancer Res; 2008; 28(5A):2769-74. PubMed ID: 19035308
[TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
[TBL] [Abstract][Full Text] [Related]
7. Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice.
Thallinger C; Skorjanec S; Soleiman A; Tzaneva S; Griss J; Rous W; Poeppl W; Weinlich G; Karimian-Teherani D; Joukhadar C
Pharmacology; 2008; 82(3):233-8. PubMed ID: 18810248
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.
Yang C; Cao H; Liu N; Xu K; Ding M; Mao LJ
Drug Des Devel Ther; 2016; 10():3755-3761. PubMed ID: 27895465
[TBL] [Abstract][Full Text] [Related]
9. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative efficacy of the somatostatin analogue TT-232 in human melanoma cells and tumours.
Schwab RE; Froidevaux S; Paku S; Tejeda M; Szende B; Pap A; Beglinger C; Eberle AN; Kéri G
Anticancer Res; 2001; 21(1A):71-5. PubMed ID: 11299792
[TBL] [Abstract][Full Text] [Related]
11. MSC, a new benzoquinone-containing natural product with antimetastatic effect.
Hidvégi M; Rásó E; Tömösközi-Farkas R; Szende B; Paku S; Prónai L; Bocsi J; Lapis K
Cancer Biother Radiopharm; 1999 Aug; 14(4):277-89. PubMed ID: 10850313
[TBL] [Abstract][Full Text] [Related]
12. Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
Stein R; Chen S; Reed L; Richel H; Goldenberg DM
Cancer; 2002 Jan; 94(1):51-61. PubMed ID: 11815960
[TBL] [Abstract][Full Text] [Related]
13. Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with conventional chemotherapeutics in malignant melanoma.
Trafalis DT; Camoutsis C; Papageorgiou A
Melanoma Res; 2005 Aug; 15(4):273-81. PubMed ID: 16034305
[TBL] [Abstract][Full Text] [Related]
14. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model.
Wack C; Becker JC; Bröcker EB; Lutz WK; Fischer WH
Melanoma Res; 2001 Jun; 11(3):247-53. PubMed ID: 11468513
[TBL] [Abstract][Full Text] [Related]
15. The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimen.
Tejeda M; Gaál D; Csuka O; Ullrich A; Schwab R; Pap A; Horváth A; Kéri G
Cancer Detect Prev; 2003; 27(2):155-62. PubMed ID: 12670528
[TBL] [Abstract][Full Text] [Related]
16. The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma.
Kiyohara E; Tamai K; Katayama I; Kaneda Y
Gene Ther; 2012 Jul; 19(7):734-41. PubMed ID: 21900962
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
[TBL] [Abstract][Full Text] [Related]
18. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
Fodstad O; Aass N; Pihl A
Int J Cancer; 1980 Apr; 25(4):453-8. PubMed ID: 7372371
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in mice.
Sanborn GE; Niederkorn JY; Gamel JW
Graefes Arch Clin Exp Ophthalmol; 1992; 230(2):192-6. PubMed ID: 1577304
[TBL] [Abstract][Full Text] [Related]
20. The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
Tejeda M; Gaal D; Barna K; Csuka O; Kéri G
Anticancer Res; 2003; 23(5A):4061-6. PubMed ID: 14666719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]